Psagot Value Holdings’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Psagot Value Holdings’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,571	Closed	-$330K	–	469
2021 Q2	$330K	Buy	+2,571	New	+$327K	0.01%	253

Other funds holding GMVD

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

TCM

Tradewinds Capital Management Bellingham, Washington $504M AUM 40.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Psagot Value Holdings's GMVD Position: Q3 2021 in Review

Psagot Value Holdings sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q3 2021, closing a stake of 2,571 shares — an estimated $330K sold.

Psagot Value Holdings first reported a position in GMVD in Q2 2021 and held it in 1 quarter. The position peaked at $330K in Q2 2021. 6 funds tracked by Wall St. Rank hold GMVD as of Q3 2021.

Psagot Value Holdings reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q3 2021 after selling out during the quarter.
Psagot Value Holdings sold 2,571 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q3 2021, an estimated $330K.
Psagot Value Holdings first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q2 2021 and held it in 1 quarter.
Psagot Value Holdings's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $330K in Q2 2021.
6 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q3 2021.

Based on Psagot Value Holdings's 13F filing for Q3 2021, filed 16 Nov 2021.